Zura Bio Ltd

Zura Bio Ltd filed an 8-K with the SEC on January 19, 2023, in connection with its business combination with JATT Acquisition Corp, a blank-check company that completed its IPO in 2021 under the ticker JATT. The SPAC was sponsored by JATT Ventures and targeted opportunities in the healthcare and life sciences sector. Following the closing of the merger, Zura Bio, a clinical-stage biopharmaceutical company focused on immunology and inflammation, began trading on Nasdaq under the ticker ZURA. The combined company is advancing a pipeline of therapeutic candidates aimed at autoimmune conditions. Sign up at SpacDesk for full filing history, sponsor profiles, and real-time deal data on this and every active SPAC transaction.